Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

The Panic-Proof Portfolio (Stockchase Research)Nutex Health Inc.NUTXPAST TOP PICKFeb 05, 2026

(A Top Pick Jan 27/26, Down 20.2%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with NUTX has triggered its stop at $126.  To remain disciplined, we recommend covering the position at this time.  

$110.33

Stock price when the opinion was issued

$148.90

As of Jun 15, 2026. Market Open.

Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

NUTX operates 27 "micro-hospitals" within 12 US states.  Analysts see an excellent runway of opportunities, expecting annual EPS growth in excess of 30% over the next five years.  It trades at 8x earnings, 3.5x book and supports a robust 63% ROE.  Cash reserves are growing, while debt is retired.  We recommend setting a stop-loss at $126, looking to achieve $204 - upside potential of 28%.  Yield 0%

(Analysts’ price target is $250.00)